Research Tools & Consumables Q1 Earnings: Waters Corporation Leads With 91.5% Revenue Growth
核心洞察
Waters Corporation (搜索) reported Q1 revenues of $1.27 billion, up 91.5% year over year, outperforming analyst expectations by 4.5% and posting the fastest growth among peers.
Mettler-Toledo (搜索) reported revenues of $947.1 million, up 7.2% year over year, exceeding analyst consensus estimates by 0.6%.
Revvity (搜索) reported revenues of $686.9 million, up 9.3% year over year, but fell short of analyst expectations by 2.6% with weaker full-year guidance.
Waters Corporation (搜索) delivered the standout performance of the first-quarter earnings season among research tools and consumables companies, reporting revenues of $1.27 billion, up 91.5% year over year and outperforming analysts' expectations by 4.5%. The company scored the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth among its peers, with the market responding favorably as the stock rose 25.6% since reporting to trade at $379.24.
Founded in 1958 and pioneering innovations in laboratory analysis for over six decades, Waters develops and manufactures analytical instruments, software, and consumables for liquid chromatography, mass spectrometry, and thermal analysis used in scientific research and quality testing. The business had a very strong quarter with an impressive beat of analysts' organic revenue estimates and revenue guidance for the next quarter exceeding analysts' expectations.
Sector Performance Overview
The life sciences subsector specializing in research tools and consumables enables scientific discoveries across academia, biotechnology, and pharmaceuticals. These firms supply a wide range of essential laboratory products, ensuring a recurring revenue stream through repeat purchases and replenishment. Their business models benefit from strong customer loyalty, a diversified product portfolio, and exposure to both the research and clinical markets.
The 10 research tools and consumables stocks tracked reported a mixed Q1. As a group, revenues beat analysts' consensus estimates by 1.3% while next quarter's revenue guidance was 2% above. Share prices have performed well, up 20.8% on average since the latest earnings results.
Company Results
Mettler-Toledo (搜索), with roots dating back to the precision balance innovations of Swiss engineer Erhard Mettler, manufactures precision weighing instruments, analytical equipment, and product inspection systems used in laboratories, industrial settings, and food retail. The company reported revenues of $947.1 million, up 7.2% year on year, exceeding analysts' expectations by 0.6%. Despite the top-line beat, it was still a mixed quarter for the company with a beat of analysts' EPS estimates. The stock is flat since reporting and currently trades at $1,308.
Revvity (搜索), formerly known as PerkinElmer until its rebranding in 2023, provides health science technologies and services that support the complete workflow from discovery to development and diagnosis to cure. The company reported revenues of $686.9 million, up 9.3% year on year, falling short of analysts' expectations by 2.6%. It was a softer quarter as it posted full-year revenue guidance missing analysts' expectations and a significant miss of analysts' full-year EPS guidance estimates. Revvity delivered the weakest performance against analyst estimates and weakest full-year guidance update in the group. Interestingly, the stock is up 31.4% since the results and currently trades at $113.70.
Sotera Health Company (搜索), with a critical role in ensuring the safety of millions of patients worldwide, provides sterilization services, lab testing, and advisory services to ensure medical devices, pharmaceuticals, and food products are safe for use. The company reported revenues of $280 million, up 10% year on year, surpassing analysts' expectations by 3.6%. It was a strong quarter as it also logged an impressive beat of analysts' organic revenue estimates and EPS in line with analysts' estimates. The stock is up 16.5% since reporting and currently trades at $17.94.
Bruker (搜索), with roots dating back to the pioneering days of nuclear magnetic resonance technology, develops and manufactures high-performance scientific instruments that enable researchers and industrial analysts to explore materials at microscopic, molecular, and cellular levels. The company reported revenues of $823.4 million, up 2.7% year on year, topping analysts' expectations by 3.4%. Overall, it was a very strong quarter as it also put up a beat of analysts' EPS and organic revenue estimates. The stock is up 62.4% since reporting and currently trades at $61.74.
Sector Outlook
Looking ahead, this subsector stands to benefit from tailwinds such as growing demand for tools supporting emerging fields like synthetic biology and personalized medicine. There is also a rise in automation and AI-driven solutions in laboratories that could create new opportunities to sell tools and consumables. Nevertheless, headwinds exist, as these companies tend to be at the mercy of supply chain disruptions and sensitivity to macroeconomic conditions that impact funding for research initiatives.